Arcadia Biosciences, Inc. — Director's Dealing 2017

Aug 10, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2017-08-07

Reporting Person: Yoder Amy (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-07	Stock Option (right to buy)	$0.43	A	202447	Acquired	2027-08-07	Common Stock (202447)	Direct

Footnotes

F1: The shares subject to the Option shall vest and become exercisable in three (3) equal annual installments, with one-third of the shares subject to the Option vesting on each of the first three (3) anniversaries of the date of the award, subject to Participant's continued service through each applicable vesting date.